Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment
Women's health is in fact a direct reflection of the nation's overall health
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
A simple blood test detects over 30 types of cancers
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
New expanded indication provides patients suffering from earlier stages of heart failure access to the CardioMEMS HF System, a small implantable sensor that can flag early warning signs of worsening heart failure
Subscribe To Our Newsletter & Stay Updated
